Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells. 2002

Norihiro Harada, and Masafumi Nakayama, and Hiroyasu Nakano, and Yoshinosuke Fukuchi, and Hideo Yagita, and Ko Okumura
Department of Immunology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan.

TWEAK, a member of the TNF family, induces cell death in some tumor cell lines, but also induces proliferation of endothelial cells and angiogenesis. Recently, fibroblast growth factor-inducible 14 (Fn14) has been identified to be a TWEAK receptor, which may be responsible for the proliferation of endothelial cells and angiogenesis. In this study, we investigated the pro-inflammatory effect of TWEAK on human umbilical vein endothelial cells (HUVEC). We demonstrated that TWEAK could not only induce the proliferation and migration but also upregulate the cell surface expression of adhesion molecules such as ICAM-1 and E-selectin, and induce the secretion of chemokines such as IL-8 and MCP-1 in HUVEC. Moreover, by using an anti-Fn14 mAb that blocks the TWEAK/Fn14 interaction, we demonstrated that Fn14 was constitutively expressed on HUVEC and totally mediated the biological effects of TWEAK on HUVEC. These results indicated that TWEAK could induce pro-inflammatory reactions via Fn14 on HUVEC.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell

Related Publications

Norihiro Harada, and Masafumi Nakayama, and Hiroyasu Nakano, and Yoshinosuke Fukuchi, and Hideo Yagita, and Ko Okumura
October 2009, Current eye research,
Norihiro Harada, and Masafumi Nakayama, and Hiroyasu Nakano, and Yoshinosuke Fukuchi, and Hideo Yagita, and Ko Okumura
January 2018, ARYA atherosclerosis,
Norihiro Harada, and Masafumi Nakayama, and Hiroyasu Nakano, and Yoshinosuke Fukuchi, and Hideo Yagita, and Ko Okumura
August 2004, Biochemical and biophysical research communications,
Norihiro Harada, and Masafumi Nakayama, and Hiroyasu Nakano, and Yoshinosuke Fukuchi, and Hideo Yagita, and Ko Okumura
January 2021, Frontiers in pharmacology,
Norihiro Harada, and Masafumi Nakayama, and Hiroyasu Nakano, and Yoshinosuke Fukuchi, and Hideo Yagita, and Ko Okumura
January 2009, The American journal of Chinese medicine,
Norihiro Harada, and Masafumi Nakayama, and Hiroyasu Nakano, and Yoshinosuke Fukuchi, and Hideo Yagita, and Ko Okumura
January 2010, The American journal of Chinese medicine,
Norihiro Harada, and Masafumi Nakayama, and Hiroyasu Nakano, and Yoshinosuke Fukuchi, and Hideo Yagita, and Ko Okumura
April 2018, Cytotechnology,
Norihiro Harada, and Masafumi Nakayama, and Hiroyasu Nakano, and Yoshinosuke Fukuchi, and Hideo Yagita, and Ko Okumura
May 2004, The Journal of investigative dermatology,
Norihiro Harada, and Masafumi Nakayama, and Hiroyasu Nakano, and Yoshinosuke Fukuchi, and Hideo Yagita, and Ko Okumura
July 2017, Molecular immunology,
Norihiro Harada, and Masafumi Nakayama, and Hiroyasu Nakano, and Yoshinosuke Fukuchi, and Hideo Yagita, and Ko Okumura
February 2010, Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova,
Copied contents to your clipboard!